Protocolo para um ensaio clínico randomizado de exercícios oculomotores adicionados ao tratamento para disfunção temporomandibular

Abstract

Background: Studies show that there is a relationship between the presence of TMD and its signs and symptoms in patients who have convergence insufficiency. Objective: the objective of this study is to verify the effect of adding oculomotor therapy to physiotherapeutic treatment for TMD of myogenic etiology, specifically about the modulation of pain intensity, range of mandibular movement, severity of TMD and its potential influence on insufficiency of ocular convergence. Materials and Methods: The design is a protocol for a randomized clinical trial. It will be divided into two moments: assessment and intervention. The analyses will be carried out using the Diagnostic Criteria for Temporomandibular Disorders: Clinical Protocol and Assessment Instruments (DC/TMD), the Fonseca Anamnestic Index (IAF), the Numerical Pain Scale (END), the Mandibular Functional Limitation Questionnaire (MFIQ), the Convergence Test (TC) and the Convergence Insufficiency Symptom Questionnaire (CISS). Individuals published with TMD will be stratified in a researched manner into two distinct groups. The Experimental Group (GE) will present a clinical intervention recognized as a reference for the approach to TMD, complemented by oculomotor therapy. In return, the Control Group (CG) will exclusively receive the protocol recognized as a reference for DTM. All participants will undergo two treatment sessions at weekly intervals and will undergo prior and subsequent assessments over one week after the conclusion of the therapeutic period. Analysis: After collecting the data, it will be tabulated and prepared adopting a significance level of 5%. Results: This is a preliminary protocol, results will be available after completion of the study. Conclusion: By adding therapy with oculomotor exercises to the treatment for TMD, it will be possible to determine the effects of exercises on symptoms resulting from TMD in individuals who have this condition and CI.